Biotechnology Value Fund portfolio
51 tracked investments, 6 on the map, $2.1B raised across the mapped portfolio.
Biotechnology Value Fund51 investments · 6 on the map · $2.1B raised- Janux TherapeuticsSeries B
- Avalo TherapeuticsPost-IPO Equity
- CG Oncology
- Verastem OncologyPost-IPO Equity
- AllakosPost-IPO Equity
- AnaptysBio
Also in the portfolio
- Nimbus Therapeutics
- Ambrosia Biosciences
- Bambusa Therapeutics
- Crossbow Therapeutics
- Tyra Biosciences
- Aro Biotherapeutics
- Dren Bio
- CinCor Pharma
- AltruBio
- Revolution Medicines
- Repare Therapeutics
- Antares Therapeutics
- Centessa Pharmaceuticals
- Cidara Therapeutics
- Pheon Therapeutics
- Third Harmonic Bio
- Ventus Therapeutics
- Simcha Therapeutics
- Lassen Therapeutics
- VistaGen
- Exo Therapeutics
- ALX Oncology
- Molecular Partners
- Inventiva Pharma
- Rain Oncology
- X4 Pharmaceuticals
- Black Diamond Therapeutics
- Cullinan Therapeutics
- ViewPoint Therapeutics
- AC Immune
- Alpine Immune Sciences
- Eledon Pharmaceuticals
- Delcath Systems
- Molecular Templates
- Point Biopharma
- ESSA Pharma
- Infinity Pharmaceuticals
- Viracta Therapeutics
- Surface Oncology
- GTx
- Pieris Pharmaceuticals
- Cascadian Therapeutics
Investors similar to Biotechnology Value Fund
OrbiMed177 investments · 137 on the map · $9.6B raised
RA Capital Management150 investments · 92 on the map · $6.7B raised
TCG Crossover27 investments · 9 on the map · $4.1B raised
RTW Investments35 investments · 11 on the map · $2.5B raised
EcoR1 Capital41 investments · 10 on the map · $6B raised
Surveyor Capital45 investments · 7 on the map · $4B raised